Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world free of postoperative complications. The company markets an innovative portfolio of solutions, including TetraGraph® and ExSpiron® 2Xi for monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate postoperative complications for more than 100 million patients worldwide. Backed by strong institutional long-term owners, our shares are listed on Nasdaq Stockholm Main Market (SEZI) and cross traded in the US on OTCQX (SNZZF).
View Top Employees from SenzimeWebsite | http://www.senzime.com |
Ticker | OTCPINK:SNZZF |
Revenue | $8 million |
Funding | $8.2 million |
Employees | 54 (54 on RocketReach) |
Founded | 1999 |
Address | 41 Ulls Väg, Uppsala, Uppsala 756 51, SE |
Phone | (461) 851-5640 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Manufacturing General, Health Diagnostics, Biotechnology, Manufacturing, Health Care, Other Commercial Products, Medical Device |
Web Rank | 12 Million |
Keywords | David R Hampton, Samtit Congress |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Senzime employee's phone or email?
The Senzime annual revenue was $8 million in 2024.
54 people are employed at Senzime.
Senzime is based in Uppsala, Uppsala.
The NAICS codes for Senzime are [334, 33].
The SIC codes for Senzime are [38, 384].